357 related articles for article (PubMed ID: 27103598)
1. Acute cardiac failure secondary to senile systemic amyloidosis.
Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
[TBL] [Abstract][Full Text] [Related]
2. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of cardiac transthyretin amyloidosis based on multimodality imaging.
Dahlem K; Michels G; Kobe C; Bunck AC; Ten Freyhaus H; Pfister R
Clin Res Cardiol; 2017 Jun; 106(6):471-473. PubMed ID: 28303323
[No Abstract] [Full Text] [Related]
4. Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.
Cappelli F; Baldasseroni S; Bergesio F; Perlini S; Salinaro F; Padeletti L; Attanà P; Paoletti Perini A; Moggi Pignone A; Grifoni E; Fabbri A; Marchionni N; Gensini GF; Perfetto F
Clin Cardiol; 2015 Feb; 38(2):69-75. PubMed ID: 25645201
[TBL] [Abstract][Full Text] [Related]
5. Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment.
Wu YA; Tsai CH; Su MY; Chao CC; Cheng MF; Shun CT; Hsieh ST; Lin YH
ESC Heart Fail; 2022 Dec; 9(6):4335-4339. PubMed ID: 36128649
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of right ventricular systolic function in cardiac amyloidosis.
Bodez D; Ternacle J; Guellich A; Galat A; Lim P; Radu C; Guendouz S; Bergoend E; Couetil JP; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Deux JF; Mohty D; Damy T
Amyloid; 2016 Sep; 23(3):158-167. PubMed ID: 27348696
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and clinical manifestations of cardiac amyloidosis.
Bajwa F; O'Connor R; Ananthasubramaniam K
Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
[TBL] [Abstract][Full Text] [Related]
8. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
González-López E; López-Sainz Á; Garcia-Pavia P
Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
Puig-Carrion GD; Reyentovich A; Katz SD
Clin Auton Res; 2019 Sep; 29(Suppl 1):45-53. PubMed ID: 31452023
[TBL] [Abstract][Full Text] [Related]
11. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
Khedraki R
Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
13. Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
Papathanasiou M; Carpinteiro A; Kersting D; Jakstaite AM; Hagenacker T; Schlosser TW; Rischpler C; Rassaf T; Luedike P
Mol Genet Genomic Med; 2021 Dec; 9(12):e1581. PubMed ID: 33345470
[TBL] [Abstract][Full Text] [Related]
14. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
Gagliardi C; Perfetto F; Lorenzini M; Ferlini A; Salvi F; Milandri A; Quarta CC; Taborchi G; Bartolini S; Frusconi S; Martone R; Cinelli MM; Foffi S; Reggiani MLB; Fabbri G; Cataldo P; Cappelli F; Rapezzi C
Eur J Heart Fail; 2018 Oct; 20(10):1417-1425. PubMed ID: 30070416
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
Ruberg FL; Grogan M; Hanna M; Kelly JW; Maurer MS
J Am Coll Cardiol; 2019 Jun; 73(22):2872-2891. PubMed ID: 31171094
[TBL] [Abstract][Full Text] [Related]
17. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Chen W; Ton VK; Dilsizian V
Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.
Kyriakou P; Mouselimis D; Tsarouchas A; Rigopoulos A; Bakogiannis C; Noutsias M; Vassilikos V
BMC Cardiovasc Disord; 2018 Dec; 18(1):221. PubMed ID: 30509186
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin amyloid cardiomyopathy.
Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
Galant NJ; Westermark P; Higaki JN; Chakrabartty A
Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
